NSTG - NanoString Technologies, Inc.
| Previous Close | 26.97 |
| Open | 27.45 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1000 |
| Day's Range | 26.74 - 27.59 |
| 52 Week Range | 11.12 - 31.14 |
| Volume | 211,474 |
| Avg. Volume | 586,487 |
| Market Cap | 938.96M |
| Beta (3Y Monthly) | 1.85 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.72 |
| Earnings Date | May 6, 2019 - May 10, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 29.33 |
- GlobeNewswire•8 days ago
NanoString to Present at the UBS Global Healthcare Conference
SEATTLE, May 15, 2019 -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products,.
- Simply Wall St.•13 days ago
Do Institutions Own NanoString Technologies, Inc. (NASDAQ:NSTG) Shares?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
Motley Fool•13 days agoNanostring Technologies (NSTG) Q1 2019 Earnings Call Transcript
NSTG earnings call for the period ending March 31, 2019.
- Thomson Reuters StreetEvents•13 days ago
Edited Transcript of NSTG earnings conference call or presentation 9-May-19 8:30pm GMT
Q1 2019 NanoString Technologies Inc Earnings Call
- Insider Monkey•13 days ago
Did Hedge Funds Drop The Ball On NanoString Technologies Inc (NSTG)?
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock. They are particularly successful in this regard when it comes to small-cap stocks, which their peerless research gives them a big information advantage on when it comes to judging their worth. […]
- Zacks•13 days ago
NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates
NanoString (NSTG) delivered earnings and revenue surprises of -6.15% and 8.91%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•13 days ago
NanoString: 1Q Earnings Snapshot
SEATTLE (AP) _ NanoString Technologies Inc. (NSTG) on Thursday reported a loss of $21.9 million in its first quarter. On a per-share basis, the Seattle-based company said it had a loss of 69 cents. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 65 cents per share.
- GlobeNewswire•13 days ago
NanoString Technologies Releases Operating Results for First Quarter of 2019
SEATTLE, May 09, 2019 -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today.
- American City Business Journals•18 days ago
Need to know: Max grounding costs mount, an Elysian remake and the story behind an Escala penthouse
Business Journal Managing Editor Rob Johnson takes readers for a casual tour of the week that was. We call it Business Journal Untucked.
- Zacks•20 days ago
Can Core Business Unit Fuel McKesson (MCK) Q4 Earnings?
Anticipated growth across core business unit and solid show by Medical Surgical and European Pharmaceutical Solutions is likely to aid McKesson's (MCK) Q4 earnings. However, rising costs might be a dampener.
- Zacks•20 days ago
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
Better-than-expected performance at Pharmaceutical and Medical segments and diverse product portfolio is likely to aid Cardinal Health (CAH) in Q3 earnings. However, stiff competition might play spoilsport.
- Zacks•21 days ago
NanoString Technologies (NSTG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
NanoString (NSTG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks•21 days ago
What's in the Cards for DaVita (DVA) This Earnings Season?
Better-than-expected performance at Kidney Care, strategic buyouts and international expansion might aid DaVita (DVA) in Q1. However, integration risks might be a dampener.
- Zacks•23 days ago
Can Steady CAG Growth Drive IDEXX's (IDXX) Q1 Earnings?
Idexx (IDXX) is expected to continue reporting solid revenue growth on robust CAG performance.
- Zacks•24 days ago
Will Pharmacy Services Drive CVS Health's (CVS) Q1 Earnings?
Within Pharmacy Services, despite a fierce pricing competition, CVS Health (CVS) is currently riding on high level of service and execution, competitive pricing and a unique integrated model.
- Zacks•28 days ago
Will Pricing Pressure Hurt Zimmer Biomet (ZBH) Q1 Earnings?
With Zimmer Biomet (ZBH) focusing solely on this restructuring initiative, chances are slim for the company to post promising growth performances across its operating segments.
- Zacks•28 days ago
Can Covance Business Growth Aid LabCorp (LH) in Q1 Earnings?
Within Covance Drug Development, LabCorp (LH) is expected to drive profitable growth through expanded solutions and enhanced operational capabilities.
- Zacks•28 days ago
Can iTotal PS Revenues Drive ConforMIS' (CFMS) Q1 Earnings?
ConforMIS (CFMS) expects to register solid revenue growth on robust performance by its product lines as well as steady royalties.
- Zacks•29 days ago
Can Front Line Care Drive Hill-Rom's (HRC) Q2 Earnings?
Hill-Rom (HRC) consistently reports strong Core revenue growth in domestic and international markets on solid segmental performance.
- Zacks•last month
Can Core Renal Care Unit Drive Baxter's (BAX) Q1 Earnings?
Strong performance across Renal Care, Clinical Nutrition, Advanced Surgery and Acute Therapies businesses might aid Baxter (BAX) in Q1. However, lower sales at Pharmaceutical business might be a woe.
- Zacks•last month
3 Medical Product Stocks Set to Beat This Earnings Season
The global medical device space takes significant strides in terms of research and development (R&D) and regulatory progress in the first quarter.
- Thomson Reuters StreetEvents•last month
Edited Transcript of NSTG earnings conference call or presentation 7-Mar-19 9:30pm GMT
Q4 2018 NanoString Technologies Inc Earnings Call
- Zacks•last month
Can Core MedSurg Segment Drive Stryker's (SYK) Q1 Earnings?
Solid segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine along with an upbeat 2019 view are likely to support Stryker (SYK) in Q1. But integration risks might be a dampener.
- GlobeNewswire•last month
NanoString to Release First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019
SEATTLE, April 08, 2019 -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today.
- Simply Wall St.•2 months ago
How Do Analysts See NanoString Technologies, Inc. (NASDAQ:NSTG) Performing Over The Next Few Years?
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! The most recent earnings release NanoString Technologies, Inc.'s (NASDAQ:NSTG) announced in December 2018 revealed...
